James Lind's 1747 Trial Was the First Controlled Experiment in Medicine

In May 1747, James Lind, a Scottish surgeon aboard HMS Salisbury, selected twelve sailors suffering from scurvy and divided them into six pairs. All twelve shared the same quarters and the same diet. The only difference was the daily treatment each pair received: cider, vitriol, vinegar, sea water, a paste of garlic and mustard, or two oranges and one lemon.

Six days later, the two men on the citrus regimen were fit enough to return to duty. The others were not.

Lind published the findings in his Treatise of the Scurvy in 1753. He was describing, without modern vocabulary, what we would now call a controlled experiment: identical baseline conditions, one variable altered, outcomes measured. The logic is so obvious now that it's easy to miss how original it was in an era when physicians explained scurvy as a miasma, a digestive disorder, a consequence of bad air, or simply the inevitable cost of long sea voyages.

Scurvy was catastrophic at sea. Estimates suggest that between 1500 and 1800, more sailors died of scurvy than in all naval combat combined. The disease destroys the body's ability to synthesize collagen — old wounds reopen, gums bleed and rot, teeth fall out, the sailor becomes too weak to stand. Vasco da Gama lost roughly 100 of his 170 men on the voyage around the Cape of Good Hope in 1497 to what historians believe was primarily scurvy. The toll on the British Navy during the Seven Years' War (1756–1763) was staggering: disease, much of it scurvy, killed far more men than French cannon.

Lind's method was not fully understood even by Lind himself. He believed the citrus worked by facilitating digestion, not by supplying a specific nutrient. He had no concept of vitamins — the word wouldn't exist for another 160 years. What he had was data. Six pairs, six interventions, one clear winner.

The Royal Navy did not adopt routine citrus rations until 1795 — 42 years after Lind's publication and six years after Lind's death. The physician who pushed hardest for the policy change was Gilbert Blane, who had served as physician to the fleet under Admiral Rodney in the Caribbean and had watched scurvy hollow out ship after ship. Blane became a Commissioner of the Sick and Hurt Board and spent years accumulating statistics. When he finally got the order through, scurvy in the Royal Navy dropped dramatically within a year.

The bureaucratic drag is the part that stays with you. Lind had the answer in 1747. Hundreds of thousands of sailors — British, French, Dutch, Spanish — suffered and died in the intervening decades from a disease that could have been prevented for the cost of a few lemons per man per week. The evidence sat in a published treatise. Admirals and physicians read it. They simply didn't act.

To complicate the story further: the Navy eventually standardized on lime juice, not lemon juice, because limes were cheaper and more available from British colonies in the Caribbean. But lime juice has significantly less vitamin C than lemon juice, and the preserved version used at sea had even less. By the late 19th century, British Arctic expeditions were taking lime juice as a precaution and still getting scurvy — because the lime juice wasn't working. This created a scientific backlash. Some physicians in the 1880s and 1890s began doubting that citrus prevented scurvy at all, setting up a regression in understanding just as germ theory was reshaping medicine.

The modern resolution came in 1932, when the Hungarian biochemist Albert Szent-Györgyi and the American chemist Charles Glen King independently isolated ascorbic acid and identified it as the missing compound. Szent-Györgyi won the Nobel Prize in Physiology or Medicine in 1937, partly for this work. The mechanism was finally clear: ascorbic acid is a cofactor for enzymes that build collagen. Without it, connective tissue fails, and the body slowly falls apart at its seams.

Lind's 1747 trial didn't know any of this. It didn't need to. The comparison was clean enough. The gap between his data and the Navy's policy change, and the later confusion introduced by the lime substitution, is a reminder that evidence in medicine rarely travels in a straight line from observation to practice. Institutional inertia, economic convenience, and the human preference for the familiar treatment over the correct one — these are not modern problems.